521 related articles for article (PubMed ID: 23686230)
21. AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity.
MacDuff DA; Demorest ZL; Harris RS
Nucleic Acids Res; 2009 Apr; 37(6):1854-67. PubMed ID: 19188259
[TBL] [Abstract][Full Text] [Related]
22. A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation.
Bennett RP; Salter JD; Smith HC
Trends Mol Med; 2018 May; 24(5):507-520. PubMed ID: 29609878
[TBL] [Abstract][Full Text] [Related]
23. Directed DNA deamination by AID/APOBEC3 in immunity.
Macduff DA; Harris RS
Curr Biol; 2006 Mar; 16(6):R186-9. PubMed ID: 16546065
[No Abstract] [Full Text] [Related]
24. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.
Koito A; Ikeda T
Front Microbiol; 2013; 4():28. PubMed ID: 23431045
[TBL] [Abstract][Full Text] [Related]
25. Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.
Izumi T; Shirakawa K; Takaori-Kondo A
Mini Rev Med Chem; 2008 Mar; 8(3):231-8. PubMed ID: 18336343
[TBL] [Abstract][Full Text] [Related]
26. Differential Evolution of Antiretroviral Restriction Factors in Pteropid Bats as Revealed by APOBEC3 Gene Complexity.
Hayward JA; Tachedjian M; Cui J; Cheng AZ; Johnson A; Baker ML; Harris RS; Wang LF; Tachedjian G
Mol Biol Evol; 2018 Jul; 35(7):1626-1637. PubMed ID: 29617834
[TBL] [Abstract][Full Text] [Related]
27. APOBEC3 proteins and reverse transcription.
Aguiar RS; Peterlin BM
Virus Res; 2008 Jun; 134(1-2):74-85. PubMed ID: 18262674
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies.
Mohammadzadeh N; Follack TB; Love RP; Stewart K; Sanche S; Chelico L
Virology; 2019 Jan; 527():21-31. PubMed ID: 30448640
[TBL] [Abstract][Full Text] [Related]
29. Deaminase-Independent Mode of Antiretroviral Action in Human and Mouse APOBEC3 Proteins.
Hakata Y; Miyazawa M
Microorganisms; 2020 Dec; 8(12):. PubMed ID: 33322756
[TBL] [Abstract][Full Text] [Related]
30. APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1.
McDonnell MM; Crawford KHD; Dingens AS; Bloom JD; Emerman M
mBio; 2020 Apr; 11(2):. PubMed ID: 32345636
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Ovine A3Z1 Restriction Properties against Small Ruminant Lentiviruses (SRLVs).
de Pablo-Maiso L; Glaria I; Crespo H; Nistal-Villán E; Andrésdóttir V; de Andrés D; Amorena B; Reina R
Viruses; 2017 Nov; 9(11):. PubMed ID: 29149056
[TBL] [Abstract][Full Text] [Related]
32. Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation.
Sabbatucci M; Covino DA; Purificato C; Mallano A; Federico M; Lu J; Rinaldi AO; Pellegrini M; Bona R; Michelini Z; Cara A; Vella S; Gessani S; Andreotti M; Fantuzzi L
Retrovirology; 2015 Jan; 12():4. PubMed ID: 25608886
[TBL] [Abstract][Full Text] [Related]
33. Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma.
Xu R; Zhang X; Zhang W; Fang Y; Zheng S; Yu XF
Hepatology; 2007 Dec; 46(6):1810-20. PubMed ID: 17847074
[TBL] [Abstract][Full Text] [Related]
34. DNA Editing by APOBECs: A Genomic Preserver and Transformer.
Knisbacher BA; Gerber D; Levanon EY
Trends Genet; 2016 Jan; 32(1):16-28. PubMed ID: 26608778
[TBL] [Abstract][Full Text] [Related]
35. Species-specific differences in the ability of feline lentiviral Vif to degrade feline APOBEC3 proteins.
Yoshikawa R; Nakano Y; Yamada E; Izumi T; Misawa N; Koyanagi Y; Sato K
Microbiol Immunol; 2016 Apr; 60(4):272-9. PubMed ID: 26935128
[TBL] [Abstract][Full Text] [Related]
36. APOBEC: A molecular driver in cervical cancer pathogenesis.
Revathidevi S; Murugan AK; Nakaoka H; Inoue I; Munirajan AK
Cancer Lett; 2021 Jan; 496():104-116. PubMed ID: 33038491
[TBL] [Abstract][Full Text] [Related]
37. Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination.
Gillick K; Pollpeter D; Phalora P; Kim EY; Wolinsky SM; Malim MH
J Virol; 2013 Feb; 87(3):1508-17. PubMed ID: 23152537
[TBL] [Abstract][Full Text] [Related]
38. Host restriction of lentiviruses and viral countermeasures: APOBEC3 and Vif.
Jónsson SR; Andrésdóttir V
Viruses; 2013 Jul; 5(8):1934-47. PubMed ID: 23903287
[TBL] [Abstract][Full Text] [Related]
39. Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.
Kohli RM; Maul RW; Guminski AF; McClure RL; Gajula KS; Saribasak H; McMahon MA; Siliciano RF; Gearhart PJ; Stivers JT
J Biol Chem; 2010 Dec; 285(52):40956-64. PubMed ID: 20929867
[TBL] [Abstract][Full Text] [Related]
40. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
Refsland EW; Hultquist JF; Harris RS
PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
